Birth defects among children born to human immunodeficiency virus-infected women: Pediatric AIDS clinical trials protocols 219 and 219C

Pediatric Infectious Disease Journal

Volumn 29, Issue 8, 2010, Pages 721-727

  Brogly, Susan B ^a,b   Abzug, Mark J ^c   Watts, D Heather ^d   Cunningham, Coleen K ^e   Williams, Paige L ^a,b   Oleske, James ^f   Conway, Daniel ^g   Sperling, Rhoda S ^h   Spiegel, Hans ⁱ   Van Dyke, Russell B ^j  

^a CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

^f UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^g DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

ⁱ MONTEFIORE MEDICAL CENTER   (United States)

^j TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

more..

Author keywords

antiretroviral therapy; congenital abnormalities anomalies; HIV; in utero exposure

Indexed keywords

ABACAVIR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; SAQUINAVIR; STAVUDINE; TENOFOVIR; ZIDOVUDINE; ANTIRETROVIRUS AGENT; BENZOXAZINE DERIVATIVE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARNOLD CHIARI MALFORMATION; ARTICLE; BIRTH DEFECT; CHILD; CLEFT PALATE; CLINICAL PROTOCOL; CONGENITAL HEART MALFORMATION; DISEASE CLASSIFICATION; FEMALE; FIRST TRIMESTER PREGNANCY; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; HEMANGIOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDRONEPHROSIS; HYPOSPADIAS; LARYNGOMALACIA; MAJOR CLINICAL STUDY; MALE; MENINGOMYELOCELE; MUSCLE HYPERTONIA; MUSCULOSKELETAL SYSTEM MALFORMATION; PES EQUINOVARUS; POLYTHELIA; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PYLORUS STENOSIS; RISK FACTOR; UMBILICAL HERNIA; ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; CLINICAL TRIAL; CONGENITAL ABNORMALITIES; INFANT; NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; YOUNG ADULT;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTI-RETROVIRAL AGENTS; BENZOXAZINES; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; YOUNG ADULT; ZIDOVUDINE;

EID: 77955173051     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3181e74a2f     Document Type: Article

References (21)

1. Perinatal HIV Guidelines Working Group; Public Health Services Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Available at:
2. Venhoff N, Walker U. Mitochondrial disease in the offspring as a result of antiretroviral therapy. Expert Opin Drug Saf. 2006;5:373-381.
3. Fundaro C, Genovese O, Rendeli C, et al. Myelomeningocele in a child with intrauterine exposure to efavirenz. AIDS. 2002;16:299-300.
4. De Santis M, Carducci B, De Santis L, et al. Periconceptional exposure to efavirenz and neural tube defects. Arch Intern Med. 2002;162:355.
5. Saitoh A, Hull A, Franklin P, et al. Myelomeningocele in an infant with intrauterine exposure to efavirenz. J Perinatol. 2005;25:555-556.
6. Nightingale S. From the food and drug administration. JAMA. 1998;280: 1472.
7. European Collaborative Study. Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. J Acquir Immune Defic Syndr. 2003;32:380-387.
8. European Collaborative Study. Does highly active antiretroviral therapy increase the risk of congenital anomalies in HIV-infected women? J Acquir Immune Defic Syndr. 2005;40:116-118.
9. Townsend C, Willey B, Cortina-Borja M, et al. Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007. AIDS. 2009;23:519-524.
10. Jungmann E, Mercey D, DeRuiter A, et al. Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities? Sex Transm Infect. 2001;77:441-443.
11. Centers for Disease Control and Prevention. Update on overall prevalence of major birth defects-Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep. 2008;57:1-5.
12. Watts D, Li D, Handelsman E, et al. Assessment of birth defects according to maternal therapy among infants in the Women and Infants Transmission Study. J Acquir Immune Defic Syndr. 2007;44:299-305.
13. Antiretroviral Pregnancy Steering Committee. Antiretroviral pregnancy registry international interim report for 1 January 1989 through 31 July 2008. Wilmington, NC: Registry Coordinating Center 2008. Available at: www.APRegistry.com.
14. Brogly S, Ylitalo N, Mofenson L, et al. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children. AIDS. 2007;21:929-938.
15. Louik C, Lin A, Werler M, et al. First-trimester use of selective serotoninreuptake inhibitors and the risk of birth defects. N Engl J Med. 2007;356: 2675-2683.
16. Correa A, Cragan JD, Kucik ME, et al. Reporting birth defects surveillance data 1968-2003. Birth Defects Res A Clin Mol Teratol. 2007;79: 65-186.
17. Sperling R, Shapiro D, McSherry G, et al. Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS. 1998;12:1805-1813.
18. Lai WW, Lipshultz SE, Easley KA, et al; P2C2 HIV Study Group, National Heart, Lung, and Blood Institute, Bethesda, Maryland. Prevalence of congenital cardiovascular malformations in children of human immunodeficiency virus-infected women: the prospective P2C2 HIV Multicenter Study. J Am Coll Cardiol. 1998;32:1749-1755.
19. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890-1900.
20. Brogly S, Read JS, Shapiro D, et al. Participation of HIV-infected pregnant women in research in the United States. AIDS Res Hum Retroviruses. 2007;23:51-53.
21. Dorenbaum A, Cunningham C, Gelber R, et al. Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial. JAMA. 2002;288:189-198.